Furthermore, since EMT is a reversible process, it would be feasible to recruit back stem-like cancer cells by inducing a reverse driver switch from Notch1 to mutant EGFR, and thus restoring sensitivity to EGFR TKIs. The gene discussed is NOTCH1; the disease is cancer.